University of Tasmania
Browse

File(s) not publicly available

Plasma concentrations of midazolam during continuous subcutaneous administration in palliative care

Version 2 2024-10-28, 04:07
Version 1 2023-05-18, 22:11
journal contribution
posted on 2024-10-28, 04:07 authored by Martin BleaselMartin Bleasel, Gregory PetersonGregory Peterson, PF Dunne
We have investigated the steady-state plasma concentrations of midazolam during continuous subcutaneous administration in palliative care. Using a sensitive gas chromatography with electron capture detector assay, plasma concentrations of midazolam were measured in 11 patients (median age 68 years; range 47-82 years; six females) receiving the drug by continuous subcutaneous infusion (median rate 20 mg/day; range 10-60 mg/day). While not significant, the infusion rate tended to decrease with increasing age of the patient (Spearman's p = -0.51; p = 0.11). The steady-state plasma concentration range was 10-147 ng/ml, with a median of 30 ng/ml. Infusion rates and plasma concentrations of midazolam were correlated (Spearman's p = 0.71; p < 0.05). No other significant relationships were found between plasma concentrations and the variables of age, sex and liver function.

History

Publication title

Palliative Medicine: A Multiprofessional Journal

Volume

8

Issue

3

Pagination

231-236

ISSN

0269-2163

Department/School

Medicine, College Office - CHM, Pharmacy

Publisher

Arnold

Publication status

  • Published

Place of publication

United Kingdom

Socio-economic Objectives

200309 Palliative care

Usage metrics

    University Of Tasmania

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC